Immunology and Immune Response Notes

Primary Immune Response

  • Definition: The primary immune response is the body's initial reaction to a pathogen (or antigen).
  • Process:
    • First exposure involves a lag phase (2-3 days or more) where the body learns to recognize the pathogen.
    • Innate immune system attempts to stop the pathogen before the adaptive immune system is activated.
  • Lag Phase: The body takes time to process the pathogen, and initial antibody response is low but gradually increases as the immune response strengthens.

Antibody Production

  • Types of Antibodies:
    • IgM: First antibody produced during a primary infection; present initially in small amounts.
    • IgG: Present during primary infections in smaller quantities but dominates in secondary infections.
  • Maternal Transfer:
    • IgG can cross the placenta to provide immunity to the fetus.
    • IgM attacks during the initial exposure, while IgG becomes prominent in case of subsequent infections.
  • Electrophoresis: A technique used to separate antibodies based on molecular weight to determine their levels in blood.

Secondary Immune Response

  • Shorter lag phase due to memory B cells from previous infections.
  • Higher levels of IgG produced during secondary infections as the body rapidly mobilizes an immune response due to memory:
    • Memory B Cells: Specialized cells that improve and expedite the antibody response during re-exposure to the same pathogen.

Active vs Passive Immunity

  • Active Immunity: Developed through exposure to pathogens or through vaccination.
  • Passive Immunity: Transfer of antibodies from one individual to another (e.g., maternal antibodies), which provides temporary protection.

Immunocompromised Individuals

  • Definition: Refers to individuals with weakened immune systems, making them more susceptible to infections.
  • Treatment: They may receive pooled IgG from multiple donors to boost immunity against various pathogens.

Herd Immunity

  • Explained as the phenomenon where a significant portion of a population becomes immune (through vaccination or previous infection), indirectly protecting those who are not immune.

Vaccines

  • Definition: Preparations that introduce antigens (epitopes) to stimulate an immune response without causing disease.
  • Types of Vaccines:
    • Attenuated Vaccines: Weakened live pathogens; elicit strong immune responses and sometimes require fewer doses.
    • Potential risks for immunocompromised individuals due to the risk of reversion to virulent forms.
    • Inactivated Vaccines: Contain killed pathogens; induce weaker immune responses and often require multiple boosters.

Immunotherapy

  • Definition: Utilizes the immune system to treat diseases, particularly cancer.
  • Mechanisms:
    • Enhances immune response by targeting specific immune cells (e.g., T cells).
    • Can involve using cytokines like Interleukin-2 (IL-2) to boost T cell activity.
    • Uses Checkpoint Inhibitors to block cancer cells from evading immune detection.
  • Risks: Can harm normal cells and suppressive responses may be necessary in autoimmune diseases where the immune system attacks the body itself.

Immunoassays

  • Definition: Tests using antigen-antibody interactions to detect diseases.
  • Types:
    • Qualitative Tests: Indicate presence or absence of antigens/antibodies (e.g., pregnancy tests).
    • Quantitative Tests: Measure concentrations of antibodies (e.g., titer tests).

Serology

  • Definition: Branch of immunology focused on blood serum and its antibodies to diagnose or monitor diseases.
  • Tests:
    • Seropositive: Indicates the presence of antibodies.
    • Seronegative: Indicates absence of antibodies.
    • Seroconversion: The process of developing antibodies in response to an infection, signifying an active infection phase.

Additional Notes

  • Importance of understanding immunological testing and categorizing vaccine types, also distinguishing between immunotherapy mechanisms and their applications in clinical practice.